Journal of Clinical Immunology

, Volume 26, Issue 6, pp 512–518 | Cite as

Type I Interferons Attenuate T Cell Activating Functions of Human Mast Cells by Decreasing TNF-α Production and OX40 Ligand Expression While Increasing IL-10 Production

  • Tomoko Fujita
  • Naotomo Kambe
  • Takashi Uchiyama
  • Toshiyuki Hori
Original Paper

Recent studies have demonstrated that mast cells not only mediate inflammatory reactions in type I allergy but also play an important role in adaptive immunity. In the present study, we investigated the effects of interferon-α, which shares the same receptor as IFN-β, on human cord blood-derived mast cells. Mast cells produced TNF-α, and IL-10, and expressed OX40 ligand upon activation by crosslinking of FcɛRI. When treated with interferon-α, TNF-α production was decreased while IL-10 and TGF-β productions were increased. Furthermore, flow cytometric analysis revealed that interferon-α downregulated expression OX40 ligand on mast cells which is crucial for mast cell-T cell interaction. We confirmed that the viability of mast cells was not affected by interferon-α treatment. Accordingly, interferon-α-treated mast cells induced lower levels of CD4+ T cell proliferation compared with those without interferon-α treatment. These results suggest that type I interferons suppress T cell immune responses through their regulatory effects on mast cells.


Mast cells CD4+ T cells Type I interferons OX40 ligand 



This work was partly supported by grants-in-aid from the Ministry of Health, Labour and Welfare of Japan.


  1. 1.
    Galli SJ: Mast cells and basophils. Curr Opin Hematol 7:32–39, 2000PubMedCrossRefGoogle Scholar
  2. 2.
    Kawakami T, Galli SJ: Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2:773–786, 2002PubMedCrossRefGoogle Scholar
  3. 3.
    McLachlan JB, Hart JP, Pizzo SV, Shelburne CP, Staats HF, Gunn MD, Abraham SN: Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol 4:1199–1205, 2003PubMedCrossRefGoogle Scholar
  4. 4.
    Nakae S, Suto H, Kakurai M, Sedgwick JD, Tsai M, Galli SJ: Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc Natl Acad Sci USA 102:6467–6472, 2005PubMedCrossRefGoogle Scholar
  5. 5.
    Frandji P, Mourad W, Tkaczyk C, Singer M, David B, Colle JH, et al.: IL-4 mRNA transcription is induced in mouse bone marrow-derived mast cells through an MHC class II-dependent signaling pathway. Eur J Immunol 28:844–854, 1998PubMedCrossRefGoogle Scholar
  6. 6.
    Frandji P, Oskeritzian C, Cacaraci F, Lapeyre J, Peronet R, David B, et al.: Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J Immunol 151:6318–6328, 1993PubMedGoogle Scholar
  7. 7.
    Skokos D, Le Panse S, Villa I, Rousselle JC, Peronet R, David B, et al.: Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J Immunol 166:868–876, 2001PubMedGoogle Scholar
  8. 8.
    Kashiwakura J, Yokoi H, Saito H, Okayama Y: T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: Comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J Immunol 173:5247–5257, 2004PubMedGoogle Scholar
  9. 9.
    Nakae S, Suto H, Iikura M, Kakurai M, Sedgwick JD, Tsai M, et al.: Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol 176:2238–2248, 2006PubMedGoogle Scholar
  10. 10.
    Pawankar R: Mast cells in allergic airway disease and chronic rhinosinusitis. Chem Immunol Allergy 87:111–129, 2005PubMedCrossRefGoogle Scholar
  11. 11.
    Araki Y, Andoh A, Fujiyama Y, Bamba T: Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats. Clin Exp Immunol 119:264–269, 2000PubMedCrossRefGoogle Scholar
  12. 12.
    Skaper SD, Facci L, Romanello S, Leon A: Mast cell activation causes delayed neurodegeneration in mixed hippocampal cultures via the nitric oxide pathway. J Neurochem 66:1157–1166, 1996PubMedCrossRefGoogle Scholar
  13. 13.
    Secor VH, Secor WE, Gutekunst CA, Brown MA: Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med 191:813–822, 2000PubMedCrossRefGoogle Scholar
  14. 14.
    Olsson Y: Mast cells in plaques of multiple sclerosis. Acta Neurol Scand 50:611–618, 1974PubMedCrossRefGoogle Scholar
  15. 15.
    Tuomisto L, Kilpelainen H, Riekkinen P: Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis. Agents Actions 13:255–257, 1983PubMedCrossRefGoogle Scholar
  16. 16.
    Rozniecki JJ, Hauser SL, Stein M, Lincoln R, Theoharides TC: Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann Neurol 37:63–66, 1995PubMedCrossRefGoogle Scholar
  17. 17.
    Virley DJ: Developing therapeutics for the treatment of multiple sclerosis. NeuroRx 2:638–649, 2005PubMedCrossRefGoogle Scholar
  18. 18.
    Berghella AM, Totaro R, Pellegrini P, Contasta I, Russo T, Carolei A, et al.: Immunological study of IFNbeta-1a-treated and untreated multiple sclerosis patients: clarifying IFNbeta mechanisms and establishing specific dendritic cell immunotherapy. Neuroimmunomodulation 12:29–44, 2005PubMedCrossRefGoogle Scholar
  19. 19.
    Imura A, Hori T, Imada K, Ishikawa T, Tanaka Y, Maeda M, et al.: The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J Exp Med 183:2185–2195, 1996PubMedCrossRefGoogle Scholar
  20. 20.
    Royer B, Varadaradjalou S, Saas P, Gabiot AC, Kantelip B, Feger F, et al.: Autocrine regulation of cord blood-derived human mast cell activation by IL-10. J Allergy Clin Immunol 108:80–86, 2001PubMedCrossRefGoogle Scholar
  21. 21.
    Carre PC, Mortenson RL, King TE, Jr., Noble PW, Sable CL, Riches DW: Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosis. J Clin Invest 88:1802–1810, 1991PubMedCrossRefGoogle Scholar
  22. 22.
    Li DQ, Luo L, Chen Z, Kim HS, Song XJ, Pflugfelder SC: JNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cells. Exp Eye Res 82:588–596, 2006 Google Scholar
  23. 23.
    de Saint-Vis B, Fugier-Vivier I, Massacrier C, Gaillard C, Vanbervliet B, Ait-Yahia S, et al.: The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol 160:1666–1676, 1998PubMedGoogle Scholar
  24. 24.
    Diamond MP, El-Hammady E, Wang R, Saed G: Regulation of transforming growth factor-beta, type III collagen, and fibronectin by dichloroacetic acid in human fibroblasts from normal peritoneum and adhesions. Fertil Steril 79:1161–1167, 2003PubMedCrossRefGoogle Scholar
  25. 25.
    Kirshenbaum AS, Worobec AS, Davis TA, Goff JP, Semere T, Metcalfe DD: Inhibition of human mast cell growth and differentiation by interferon gamma-1b. Exp Hematol 26:245–251, 1998PubMedGoogle Scholar
  26. 26.
    Ndhlovu LC, Ishii N, Murata K, Sato T, Sugamura K: Critical involvement of OX40 ligand signals in the T cell priming events during experimental autoimmune encephalomyelitis. J Immunol 167:2991–2999, 2001PubMedGoogle Scholar
  27. 27.
    Bissonnette EY, Chin B, Befus AD: Interferons differentially regulate histamine and TNF-alpha in rat intestinal mucosal mast cells. Immunology 86:12–17, 1995PubMedGoogle Scholar
  28. 28.
    Riccardi-Arbi R, Bacci S, Romagnoli P, Rucci L: Interferon-alpha affects the tumour necrosis factor-alpha content of mast cells in human nasal mucosa. A pilot study in allergic patients. Ital J Anat Embryol 109:115–122, 2004PubMedGoogle Scholar
  29. 29.
    Akdis M, Blaser K, Akdis CA: T regulatory cells in allergy. Chem Immunol Allergy 91:159–173, 2006PubMedCrossRefGoogle Scholar
  30. 30.
    Carboni S, Aboul-Enein F, Waltzinger C, Killeen N, Lassmann H, Pena-Rossi C: CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis. J Neuroimmunol 145:1–11, 2003PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Tomoko Fujita
    • 1
  • Naotomo Kambe
    • 2
  • Takashi Uchiyama
    • 1
  • Toshiyuki Hori
    • 1
  1. 1.Department of Hematology and Oncology, Graduate School of MedicineKyoto UniversityKyotoJapan
  2. 2.Department of DermatologyGraduate School of Medicine, Kyoto UniversityKyotoJapan

Personalised recommendations